Vivint Pharma

Executive Summary

Vivint Pharma Pvt. Ltd. is an Indian pharmaceutical company established in 2020, focusing on the development and manufacture of affordable critical-care formulations for global markets. Based in Hyderabad, the company leverages in-house pharmaceutical chemistry and a state-of-the-art R&D and manufacturing hub to address the need for high-quality, accessible treatments in critical care and general medicine. As a commercial-stage private entity, Vivint Pharma aims to penetrate emerging and developed markets with cost-effective alternatives to established drugs, potentially improving treatment outcomes and reducing healthcare costs. While the company has not disclosed specific financials, its focus on critical care positions it in a high-demand segment with steady growth prospects.

Upcoming Catalysts (preview)

• Q3 2026Launch of a new generic critical-care drug in India70% success
• Q1 2027WHO prequalification or export approval for a key formulation60% success
• TBDStrategic partnership or licensing deal with a global pharma50% success